History
VEROVACCiNES spun off Martin-Luther-University Halle-Wittenberg in 2017. After validating the novel technology platform (Proof of Concept in several vaccine programs), we are pursuing development of our product pipeline and scaling up manufacturing.
More about us
09/2022
Feasibility of production scale up
02/2022
10/2021
07/2018
Move to own facility
04/2018
03/2018
Patents transferred from university to Verovaccines
12/2017
Seed investment round
12/2017
Filing multivalency patent
07/2017
Foundation Verovaccines GmbH
12/2014
Hugo Junkers prize
04/2014
Dr. Hennemann joins team
2009
Start research on technology